Displaying 1 - 1 of 1
| Active Ingredient | TAMOXIFEN |
| Therapeutic Class | ANTINEOPLASTICS |
| Indications | Adjuvant endocrine therapy of node-positive breast cancer. |
| Caution |
Hot flashes, vaginal bleeding, pruritis vulvae, tumor flare, rarely fluid retention, cataracts, retinopathy , visual disturbances, venous thrombosis. |
| Dose Range | 20mg daily as a single or in 2 divided doses. Max. 40mg daily . |
| Drug Interactions | |
| Pregnancy | Tamoxifen is contraindicated in pregnancy as it may cause fetal harm. |
| Breast Feeding | Tamoxifen suppresses lactation. Liscensed product information recommends that it More ... |